de la GillesTourette G.Étude sur une affection nerveuse caractérisée par l'incoordination motorice accompagnée d'écholalie et de coprolalie. Archives de neurologie (Paris). 1885;9:19–42,158–200.
2.
RobertsonMMEapenVCavannaAE. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: A cross-cultural perspective. J Psychosom Res. 2009;67:475–483.
3.
FreemanRDFastDKBurdLAn international perspective on Tourette syndrome: Selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol. 2000;42:436–447.
4.
RoessnerVPlessenKJRothenbergerAEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: Pharmacological treatment. Eur Child Adolesc Psychiatry. 2011a;20:173–196.
5.
RoessnerVRothenbergerARickardsHEuropean clinical guidelines for Tourette syndrome and other tic disorders. Eur Child Adolesc Psychiatry. 2011b;20:153–154.
6.
MinkJWWalkupJFreyKAPatient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2006;21:1831–1838.
7.
ThibertALDayHISandorP.Self-concept and self-consciousness in adults with Tourette syndrome. Can J Psychiatry. 1995;40:35–39.
8.
PringsheimTLangAKurlanRUnderstanding disability in Tourette syndrome. Dev Med Child Neurol. 2009;51:468–472.
9.
LeckmanJFZhangHVitaleACourse of tic severity in Tourette syndrome: The first two decades. Pediatrics. 1998;102:14–19.
10.
PringsheimTDojaAGormanDCanadian guidelines for the evidence-based treatment of tic disorders: Pharmacotherapy. Can J Psychiatry. 2012;57(3):133–143.
11.
SteevesTMcKinlayBDGormanDCanadian guidelines for the evidence-based treatment of tic disorders: Behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012;57(3):144–151.